Beta Drugs Ltd share price logo

Beta Drugs Ltd Share Price

(BETA)

₹19152.64%

as on 04:01PM, 04 Apr 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Beta Drugs Ltd Performance

  • Day's Low

    ₹1,862
    Day's Price Range
    ₹1,915
  • 52 Week's Low

    52 Week's High

    ₹58.96
    52-Week Price Range
    ₹2,215.24
1 Month Return+ 12.01 %
3 Month Return-0.34 %
1 Year Return+ 44.32 %
Previous Close₹1,966.85
Open₹1,895.05
Volume3,990.00
Upper Circuit₹2,360.20
Lower Circuit₹1,573.50
Market Cap₹1,914.68Cr

Beta Drugs Ltd Fundamentals

P/E Ratio

0

PEG Ratio

0

Market Cap

₹1,914.68 Cr

P/B Ratio

10.22

EPS

37.9

Dividend Yield

0

Sector

Pharmaceuticals

ROE

20.67

Key events for Beta Drugs Ltd

  • Beta Drugs Reports Strong Growth and Bonus Issue - 22 Mar, 2025

    Beta Drugs Limited announced a 60% revenue increase and 50% net profit growth in Q3FY25. A Board Meeting is set for March 27, 2025, to discuss a bonus share allotment.

Insights on Beta Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 31.95% to 32.20% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, BETA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, BETA stock has moved up by 28.7%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 66.73% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 54.3% return, outperforming this stock by 6.3%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.15% to 0.90% in Mar 2025 quarter

Beta Drugs Ltd Financials

Value in ₹ crore
Details2021202220232024
Total Assets₹86.23Cr (-)₹110.90Cr (↑28.61%)₹134.04Cr (↑20.87%)₹170.47Cr (↑27.18%)
Total Liabilities₹22.82Cr (-)₹33.44Cr (↑46.54%)₹37.79Cr (↑13.01%)₹54.46Cr (↑44.11%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹6.09Cr (-)₹11.60Cr (↑90.48%)₹18.76Cr (↑61.72%)₹10.23Cr (↓45.47%)₹21.19Cr (↑107.14%)

Beta Drugs Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
66.73%
0.00
Foreign Institutions
0.9%
0.00
Mutual Funds
0%
0.00
Retail Investors
32.2%
0.00
Others
0.17%
0.00

Beta Drugs Ltd Key Indicators

Details20202021202220232024
Return On Equity %14.6311.6520.2321.6720.67
Details20202021202220232024
Return On Assets %11.4613.5922.3922.9221.38
Details20202021202220232024
Book Value Per Share (₹)56.5967.9796.05121.73163.43
Details20202021202220232024
Earning Per Share (₹)9.3211.6225.8230.4337.9

Beta Drugs Ltd Technicals Summary

Bearish

Neutral

Bullish

Bullish

Beta Drugs Ltd is currently in a Bullish trading position according to technical analysis indicators.

Beta Drugs Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹1,914.68 Cr777.46%0.54₹36 Cr₹295 Cr
NA₹195.54 Cr21.33%1.00NANA
NA₹73.31 Cr89.24%0.51NANA
NA₹3,265.64 Cr47.52%0.58-₹154 Cr₹2,615 Cr
NA₹32.43 Cr-4.77%0.78NANA

About Beta Drugs Ltd

Beta Drugs Limited is a part of the Adley Group, established in 1985 by its promoter Vijay Batra. It is a pharmaceutical formulation manufacturing company that produces and markets drugs to domestic and international customers. The Company specializes in the production of oncology products such as anticancer tablets, capsules, injections and lyophilized injections. With a portfolio of over 50 products catering to various oncology diseases such as breast cancer, brain cancer, bone cancer, lung cancer, mouth cancer, head and neck cancer, prostate cancer, haematology and cervics oeaophagus, Beta Drugs is an important contributor to the healthcare industry. The Company was originally incorporated in Himachal Pradesh in 2005 as a private limited company and was converted into a public limited company in 2017. Under the charge of Vijay Batra, Beta Drugs has become a well-recognized and trusted international healthcare brand.

Listing date: 12 Oct, 2017
Chairperson Name: Rahul Batra
OrganisationBeta Drugs Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Beta Drugs Ltd

What is Beta Drugs Ltd price today?

Beta Drugs Ltd share price today stands at ₹1915, Open: ₹1895.05, Previous Close: ₹1966.85, High: ₹1915, Low: ₹1862, 52 Week High: ₹2215.24, 52 Week Low: ₹58.96.

How to Buy Beta Drugs Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Beta Drugs Ltd shares

What are today's traded volumes of Beta Drugs Ltd?

Today's traded volume of Beta Drugs Ltd(BETA) is 3,990.00.

What is today's market capitalisation of Beta Drugs Ltd?

Today's market capitalisation of Beta Drugs Ltd(BETA) is ₹1914.68Cr.

What is the 52 Week High and Low Range of Beta Drugs Ltd?

Beta Drugs Ltd (BETA)
Price
52 Week High
₹2215.24
52 Week Low
₹58.96

How much percentage Beta Drugs Ltd is down from its 52 Week High?

Beta Drugs Ltd (BETA) share price is ₹1915. It is down -13.55% from its 52 Week High price of ₹2215.24

How much percentage Beta Drugs Ltd is up from its 52 Week low?

Beta Drugs Ltd (BETA) share price is ₹1915. It is up 3147.96% from its 52 Week Low price of ₹58.96